JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Complemento en enfermedades humanas: terapias aprobadas y futuras

  • 0Complement and Inflammation Research Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Lancet +

|

18 de noviembre de 2023

|

18 de noviembre de 2023

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

El sistema del complemento protege contra los patógenos, pero su desregulación causa enfermedades inflamatorias. Las nuevas terapias complementarias son prometedoras para enfermedades raras y potencialmente comunes.

Área De La Ciencia

  • Inmunología
  • Farmacología

Sus Antecedentes

  • El sistema del complemento es crucial para la defensa inmune y la homeostasis de los tejidos.
  • La actividad desregulada del complemento contribuye a las enfermedades inflamatorias y autoinmunes.
  • La orientación del sistema de complemento para el beneficio terapéutico es un objetivo de larga data, pero las tasas de aprobación de medicamentos han sido modestas.

Objetivo Del Estudio

  • Revisar el progreso y los desafíos en el desarrollo de terapias complementarias.
  • Destacar objetivos novedosos y tecnologías emergentes en el desarrollo de medicamentos complementarios.
  • Discutir la posible expansión de las terapias dirigidas al complemento a enfermedades comunes.

Principales Métodos

  • Revisión de la literatura científica sobre biología y terapéutica del sistema del complemento.
  • Análisis de los datos de ensayos clínicos y tendencias de aprobación de medicamentos.
  • Discusión de los avances en las tecnologías de descubrimiento y desarrollo de medicamentos.

Principales Resultados

  • El eculizumab anticuerpo anti-C5 ha demostrado éxito en el tratamiento de la hemoglobinuria paroxística nocturna y el síndrome hemolítico atípico.
  • Una mayor comprensión de las vías del complemento ha identificado nuevos objetivos terapéuticos.
  • Es evidente el aumento del interés y el desarrollo de nuevas terapias complementarias.

Conclusiones

  • Los avances en la biología del complemento y las tecnologías de desarrollo de fármacos están impulsando la innovación en la terapia del complemento.
  • Si bien los medicamentos aprobados actualmente se dirigen principalmente a enfermedades raras, la tubería sugiere oportunidades futuras para afecciones inflamatorias comunes.
  • Dirigirse al sistema del complemento sigue siendo una estrategia prometedora para el manejo de una serie de enfermedades.

Videos de Conceptos Relacionados

Targeted Cancer Therapies 02:57

7.7K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Microorganisms in Medicine and Therapeutics 01:29

35

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Drug Discovery: Overview 01:26

8.0K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Tumor Immunotherapy 01:27

530

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Transducer Mechanism: Enzyme-Linked Receptors 01:27

2.5K

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor tyrosine kinases:

Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...

Clinical Trials: Overview 01:11

3.0K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...